Tevogen Bio Ownership | Who Owns Tevogen Bio?


OverviewRevenueFinancialsChart

Tevogen Bio Ownership Summary


Tevogen Bio is owned by 0.73% institutional investors, 79.36% insiders, and 19.91% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 0.84% of TVGN shares.

TVGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTevogen Bio0.73%79.36%19.91%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de1.55M0.84%$1.22M
Vanguard group1.09M0.59%$854.89K
Geode capital management549.67K0.30%$431.65K
Northern trust189.95K0.10%$149.16K
Morgan stanley126.66K0.07%$99.46K
Goldman sachs group121.12K0.07%$95.12K
State street115.10K0.06%$90.39K
Fmr106.01K0.06%$83.25K
Sei investments90.25K0.05%$70.88K
Nuveen90.25K0.05%$70.88K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Abel hall14.17K0.01%$17.72K
China universal asset management34.48K0.00%$27.08K
Bridgeway capital management82.50K0.00%$64.79K
Virtu financial14.45K0.00%$11.00K
Fny investment advisers1.00K0.00%$1.00K
Tower research capital llc (trc)13.26K0.00%$10.41K
Intech investment management14.24K0.00%$11.18K
Ameritas investment partners2.14K0.00%$1.68K
Sei investments90.25K0.00%$70.88K
Gf fund management4.09K0.00%$3.21K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de1.55M-81.99K
Goldman sachs group121.12K-41.04K
Bridgeway capital management82.50K0.00%33.00K
Virtu financial14.45K0.00%14.45K
Bank of new york mellon56.33K-9.32K

Top Sellers

HolderShares% AssetsChange
Xtx topco---58.81K
Ubs group40.90K--40.22K
State street115.10K--28.69K
Morgan stanley126.66K--22.27K
Two sigma securities---21.68K

New Positions

HolderShares% AssetsChangeValue
Virtu financial14.45K0.00%14.45K$11.00K
Fny investment advisers1.00K0.00%1.00K$1.00K
Srs capital advisors88.00-88.00$69.00
Sbi securities1.00-1.00$1.00

Sold Out

HolderChange
True wealth design-20.00
Headlands-341.00
Cwm-920.00
Physician wealth advisors-1.01K
Sih partners, lllp-10.57K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202515-70.00%1,340,664-70.54%-9.15%4-85.71%7-46.15%
Jun 30, 2025548.00%4,803,63624.71%252.26%323.23%13-7.14%
Mar 31, 20251-97.50%50,000-97.83%-1.86%--100.00%--100.00%
Dec 31, 20244227.27%2,408,376-57.37%112.84%3233.33%6-
Sep 30, 20243322.22%5,649,636-0.60%324.43%24-4.00%6500.00%

Recent Insider Transactions


DateNameRoleActivityValue
Jun 09, 2025Saadi Ryan H. Chief Executive OfficerSell$1.77M
Mar 12, 2025Flomenberg Neal See RemarksSell$253.94K
Mar 11, 2025Flomenberg Neal See RemarksSell$73.76K
Mar 07, 2025Flomenberg Neal See RemarksSell$81.25K
Mar 10, 2025Flomenberg Neal See RemarksSell$76.72K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q3--
2025 Q2-1
2025 Q1-7
2024 Q4-1

TVGN Ownership FAQ


Who Owns Tevogen Bio?

Tevogen Bio shareholders are primarily institutional investors at 0.73%, followed by 79.36% insiders and 19.91% retail investors. The average institutional ownership in Tevogen Bio's industry, Biotech Stocks , is 45.22%, which Tevogen Bio falls below.

Who owns the most shares of Tevogen Bio?

Tevogen Bio’s largest shareholders are Blackrock funding, inc. /de (1.55M shares, 0.84%), Vanguard group (1.09M shares, 0.59%), and Geode capital management (549.67K shares, 0.30%). Together, they hold 1.73% of Tevogen Bio’s total shares outstanding.

Does Blackrock own Tevogen Bio?

BlackRock is not among the top 10 institutional shareholders of Tevogen Bio.

Who is Tevogen Bio’s biggest shareholder by percentage of total assets invested?

Abel hall is Tevogen Bio’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 14.17K Tevogen Bio shares, valued at 17.72K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools